| abstract |
The present invention relates to a compound of formula (I) (Wherein X and R 1 to R 6 are as defined in the description and claims) The present invention relates to a novel sulfinylphenyl or sulfonimidylphenylbenzazepine compound and a pharmaceutically acceptable salt thereof. Such compounds are TLR agonists and thus for the treatment of diseases such as cancer, autoimmune diseases, inflammation, sepsis, allergy, asthma, graft rejection, graft-versus-host disease, immunodeficiency, and infections. It may be useful as a pharmaceutical. [Selection figure] None |